SCHEMBL15433153

SCHEMBL15433153

CNC(=O)Cc1ccc(CCCCc2ccccn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
GLS O94925 2/20 0.48
KMT2A Q03164 3/20 0.47
TRPV1 Q8NER1 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TDP1 Q9NUW8 3/20 0.47
ALOX15 P16050 2/20 0.47
HPGD P15428 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
MEN1 O00255 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 2/20 0.45
TAAR1 Q96RJ0 1/20 0.45
HRH1 P35367 1/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4579337 0.87 HDAC1 (0.54) POLBGLSKMT2AL3MBTL1TDP1
SCHEMBL10094805 0.82 TRPV1 (0.63) KMT2ATRPV1L3MBTL1HPGDMEN1
SCHEMBL16561480 0.81 SMN1; SMN2 (0.60) TDP1ALOX15HPGDCYP1A2CYP2C19
SCHEMBL15433155 0.81 TRPV1 (0.66) KMT2ATRPV1L3MBTL1HPGDMEN1
SCHEMBL1032275 0.80 SMN1; SMN2 (0.53) POLBGLSTDP1ALOX15HPGD
SCHEMBL15433156 0.79 SMN1; SMN2 (0.50) TRPV1HPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL10094798 0.79 GAA (0.62) KMT2ATRPV1L3MBTL1HPGDMEN1
SCHEMBL12851363 0.77 HRH3 (0.56) KMT2ATDP1ALOX15HPGDCYP1A2
SCHEMBL15433157 0.76 TRPV1 (0.61) GLSTRPV1L3MBTL1TDP1CYP1A2
SCHEMBL14137756 0.76 ALDH1A1 (0.66) TRPV1HPGDLMNAALDH1A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140024608-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF METHYLGENE INC. (CA) 2014-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140024608-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF HDAC1, HDAC3, HDAC11 POLB 1123/4885GLS 1226/4885KMT2A 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.